
GC15654
SBI-0206965
Also known as 2-[5-bromo-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]oxy-N-methylbenzamide
SBI-0206965 , the pyrimidine derivative , is a highly selective kinase ULK1 inhibitor with an IC50 value of 108nM
ChemicalCAS1884220-36-3MW489.32FormulaC21H21BrN4O5
- CAS number
- 1884220-36-3
- Molecular weight
- 489.32
- Formula
- C21H21BrN4O5
- Solubility
- ≥ 24·5mg/mL in DMSO
- InChIKey
- NEXGBSJERNQRSV-UHFFFAOYSA-N
- Catalogue number
- GC15654
- Brand
- GLPBIO
Computed properties PubChem CID 92044402 · XLogP 3.8 · TPSA 104 Ų · H-bond donors 2
- XLogP
- 3.8
- TPSA
- 104 Ų
- H-bond donors
- 2
- H-bond acceptors
- 8
- Rotatable bonds
- 8
- Heavy atoms
- 31
SMILES CNC(=O)C1=CC=CC=C1OC2=NC(=NC=C2Br)NC3=CC(=C(C(=C3)OC)OC)OC
Computed descriptors from PubChem (CID 92044402), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il